ENTITY

Dicerna Pharmaceuticals (DRNA US)

Analysis

Health Care • United States

Dicerna Pharmaceuticals, Inc. provides biopharmaceutical products. The Company discovers and develops ribonucleic acid for the treatment of liver diseases and cancer.

Refresh

Focused

No publications yet

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00